• Back to Asia: A Sneak Peak of Bio-IT World Asia

    May 1, 2013, 07:00 AM by Michael Croft
    Bio-IT World | Bio-IT World is hosting its second annual Bio-IT World Asia event in Singapore at the end of May—expanded to five tracks. If the plush location at the Marina Bay Sands hotel wasn’t incentive enough, there are four days packed with essential life sciences programming covering IT infrastructure, the cloud, clinical and cancer genomics, bioinformatics and more.
    Full story
  • It’s Time for Wheels on the Big Data Sports Car

    Apr 30, 2013, 07:00 AM by Michael Croft
    Bio-IT World Guest Commentary | Our ‘always-on’ digital world has made data a key resource which is fundamentally changing our lives. We’re swimming in it—oceans of it. So why are we still bemoaning a lack of open access to decision-making data and an innovation deficit? Big Data is here, so how do we make sense of this brave new world?
    Full story
  • NIH Seeks New ADDition in a Data Science Director

    Apr 29, 2013, 12:00 PM by Michael Croft
    Bio-IT World | BETHESDA, MD—With two weeks left to the application deadline, the National Institutes of Health (NIH) is still searching for the ideal candidate to fill a plumb new job in biomedical data science.
    Full story
  • NVIDIA Cancels Latest Kepler GPU Line

    Apr 29, 2013, 09:00 AM by Michael Croft
    SemiAccurate | SemiAccurate reports that NVIDIA has canceled its GK11x line in its Kepler GPU family, replacing it with a reworked GK10x. The rollback is a red flag for NVIDIA, SemiAccurate says.
    Full story
  • What the Thermo-Life Tech Deal Means for Illumina

    Apr 29, 2013, 08:00 AM by Michael Croft
    Xconomy | Luke Timmerman argues that the Thermo/Life Technologies deal is only good news for Illumina. Big mergers present organizational challenges, and while Thermo and Life and sorting out the details, Illumina can carry on with its market leading technology.
    Full story
  • Swing Batter, Batter: GPUs and Baseball

    Apr 29, 2013, 07:00 AM by Michael Croft
    Bio-IT World News Brief | A pair of researchers in Japan has used NVIDIA GPUs and the CUDA parallel programming model to create a 100,000-neuron simulation of the human cerebellum. And then they taught a robot to hit a baseball. The work was begun at the RIKEN Brain Science Institute, and was published online in Neural Networks last February.
    Full story
  • Sandy Aronson on GeneInsight

    Apr 26, 2013, 13:00 PM by Michael Croft
    Bio-IT World Video | Sandy Aronson, Executive Director of IT of the Partners HealthCare Center for Personalized Genetic Medicine (PCPGM), speaks with Bio-IT World Editor Kevin Davies about the GeneInsight IT platform.
    Full story
  • Personalizing an End to Cancer

    Apr 26, 2013, 10:00 AM by Michael Croft
    Bio-IT World | BOSTONIn a presentation marked by equal parts melancholy and excitement, Dr. Kevin Hrusovsky spoke at the 2013 Bio-IT World Expo on some of the recent advancements and setbacks in cancer therapeutics.
    Full story
  • Big Data, Big Loopholes

    Apr 26, 2013, 05:00 AM by Michael Croft
    Computerworld | Big data can be a big security headache. The biggest security loophole? The Hadoop cluster, according to security company Zettaset.
    Full story
  • Opscode, IBM to Offer Chef Server in IBM SmartCloud

    Apr 25, 2013, 08:15 AM by Michael Croft
    eWeek | Opscode, the maker of open-source automation platform Chef, is collaborating with IBM. IBM will support Chef Server in IBM SmartCloud.
    Full story
  • AWS Increases Security Offerings

    Apr 24, 2013, 15:00 PM by Michael Croft
    Computerworld | Amazon Web Services (AWS) is planning to increase the level of protection users can get in its cloud with hosted intrusion protection appliances and more extensive encryption features.
    Full story
  • John Halamka on the Future State of Care

    Apr 24, 2013, 10:00 AM by Michael Croft
    Bio-IT World Video | Major changes loom on the horizon for health care. John Halamka, CIO of Beth Israel Deaconess Medical Center shares his outlook on the future state of care with Bio-IT World Editor-in-Chief, Kevin Davies.
    Full story
  • Watson's Coming Challenges

    Apr 24, 2013, 08:00 AM by Michael Croft
    Forbes | The challenges for IBM's Watson extend beyond just knowing the scientific literature. That part is easy for the supercomputer.
    Full story
  • GSK Invests in Drug Discovery Startups

    Apr 23, 2013, 13:00 PM by Michael Croft
    Xconomy | GlaxoSmithKline is providing as much as $465 million in startup funds for Avalon Ventures to invest in drug-discovery companies over the next three years.
    Full story
  • Roche Shuts Down Third-Generation NGS Research Programs

    Apr 23, 2013, 12:00 PM by Michael Croft
    Bio-IT World | News that Roche is merging and laying off some 170 workers in Germany and Branford, CT, does not bode well for its efforts to reclaim some momentum in next-generation sequencing.
    Full story
  • AstraZeneca Builds Up Swedish R&D Potential

    Apr 23, 2013, 09:00 AM by Michael Croft
    Bio-IT World | Astra Zeneca continues to build up its R&D potential. The company announced its plans to strengthen its relationship with the Stockholm-based Karolinska Institute (KI), one of Europe's largest and most prestigious medical universities.
    Full story
  • Big Investments Behind Precision Medicine

    Apr 23, 2013, 08:00 AM by Michael Croft
    New York Times | Major medical centers are gearing up for a push for precision medicine. Skeptics would claim it's all a bit premature. But Robert C. Green at Brigham and Women’s Hospital in Boston counters, "What was there to look up on the Internet when the first person got a personal computer? Very little.”
    Full story
  • Deanna Church on the Reference Genome Past, Present and Future

    Apr 22, 2013, 06:00 AM by Michael Croft
    Bio-IT World | Few have spent as much time gazing upon the Reference as Deanna Church at the National Center for Biotechnology Information. Bio-IT World editor Kevin Davies skyped with Church to hear her personal assessment of the current state of the Reference, the degree of progress in the past decade and priorities for the future.
    Full story
  • Big Biotech Growing Faster than Big Pharma Says Burrill Report

    Apr 19, 2013, 09:00 AM by Michael Croft
    PharmaTimes | A new report from Burrill, says that Big Biotech has outpaced Big Pharma in terms of growth of sales, income, investment in R&D and market cap during the past three years.
    Full story
  • Flying Cars and Adaptive Drug Design: What are the Big Promises for Drug Discovery

    Apr 18, 2013, 15:00 PM by Michael Croft
    Bio-IT World | BOSTON—As the opening keynote at the 2013 Bio-IT World Conference & Expo, Andrew Hopkins started with the hard questions: Where are the flying cars?
    Full story